Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AC Immune S.A. (NQ: ACIU )

3.540 +0.130 (+3.81%)
Streaming Delayed Price Updated: 2:11 PM EDT, Aug 15, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 36,132
Open 3.420
Bid (Size) 3.520 (1)
Ask (Size) 3.540 (43)
Prev. Close 3.410
Today's Range 3.370 - 3.540
52wk Range 2.060 - 12.61
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga

Performance

YTD
-31.40%
-31.40%
1 Month
+5.36%
+5.36%
3 Month
+18.39%
+18.39%
6 Month
-18.43%
-18.43%
1 Year
-45.45%
-45.45%

More News

Read More
Recap: AC Immune Q1 Earnings
Via Benzinga
AC Immune: Q4 Earnings Insights
Via Benzinga
63 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Dow Dips 900 Points; AC Immune Shares Slide
Via Benzinga
Mid-Day Market Update: Dow Tumbles 700 points; Advent Technologies Shares Spike Higher
Via Benzinga
37 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; US Jobless Claims Fall To 229,000
Via Benzinga
Roche-AC Immune's Crenezumab Fails To Show Benefit In Sub-Set Of Alzheimer's Patients
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
27 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Moderna Files For 2nd COVID Booster Shot Authorization, Lexicon Secures Debt Funding, Amneal Gets Sub-License to Manufacture Generic COVID Pill
Via Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Via Benzinga
AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial
Via Benzinga
76 Biggest Movers From Yesterday
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Via Benzinga
Exposures COVID-19
26 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Via Benzinga
What Leerink, Wainwright Have To Say For This Alzheimer's Focused Firm
Via Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Via Benzinga
Mid-Afternoon Market Update: Spok Holdings Surges On Takeover Offer; Sequential Brands Shares Slide
Via Benzinga
Topics Stocks
Exposures US Equities
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
Via Benzinga
55 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.